Related Experiment Video

Updated: Mar 20, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K

Delivery strategies and potential targets for siRNA in major cancer types

So Jin Lee1,2, Min Ju Kim1,2,3, Ick Chan Kwon2,3

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.

Advanced Drug Delivery Reviews
|June 5, 2016
PubMed

Insights

Small interfering RNA (siRNA) offers a promising therapeutic approach for genetic diseases and cancer by inhibiting specific genes. Effective cancer treatment requires optimized siRNA delivery strategies and careful selection of gene targets.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • Small interfering RNA (siRNA) demonstrates potential as a therapeutic agent for genetic diseases by silencing specific genes.
  • Research in siRNA has advanced significantly, focusing on novel cancer treatment strategies.
  • Cancer arises from mutations in numerous genes, including proto-oncogenes and tumor suppressor genes.

Purpose of the Study:

  • To review modifications and delivery strategies for siRNA.
  • To discuss current approaches for selecting gene targets in major tumor types for siRNA therapy.

Main Methods:

  • Literature review of siRNA modifications.
  • Analysis of various siRNA delivery systems.
  • Examination of gene target selection methodologies in oncology.

Main Results:

  • Various siRNA modifications and delivery strategies are available for therapeutic development.
  • Careful design of delivery and precise gene target selection are crucial for effective siRNA cancer therapy.

Conclusions:

  • siRNA technology holds significant promise for treating genetic diseases and various cancers.
  • Further research into optimized delivery and target selection will enhance siRNA's therapeutic efficacy in oncology.
Keywords:
CancerDelivery strategy of siRNAsGene targetSmall interfering RNA (siRNA)siRNA therapeutics

More Related Videos

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.0K
TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

6.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K